Thank you!

Your quote has been successfully submitted!

For products requiring additional information, our team will contact you within 1 business day

Failed

There was an error submitting your quote. Please try again.

Recombinant Human PCSK9 Protein (AVI Tag)(Active)– MSE Supplies LLC

Free Shipping on MSE PRO Online Orders of $500 or More! U.S. Orders Only * Offer Excludes Hazmat Shipments *

Menu

This product has been added to the cart.

Recombinant Human PCSK9 Protein (AVI Tag)(Active)

SKU: PKSH032946-100

  • £86200
  • Save £9500



Recombinant Human PCSK9 Protein (AVI Tag)(Active)

 

SKU # PKSH032946
Expression Host HEK293 Cells

 

 

Description

Synonyms NARC-1, NARC1, Neural Apoptosis-Regulated Convertase 1, PC9, PCSK9, Proprotein Convertase 9, Proprotein Convertase Subtilisin/Kexin Type 9, Subtilisin/Kexin-Like Protease PC9
Species Human
Expression Host HEK293 Cells
Sequence Gln31-Gln692(Val474Ile,Gly670Glu)
Accession Q8NBP7
Calculated Molecular Weight 14&59 kDa
Observed Molecular Weight 19&65 kDa
Tag C-Avi
Bio-activity Immobilized Human LDLR-His(Cat: PKSH033435) at 10μg/ml(100 μl/well) can bind Human PCSK9-BiotinylatedAVI. The ED50 of Human PCSK9-BiotinylatedAVI is 126.41ug/ml.
  

 

Properties

Purity > 95 % as determined by reducing SDS-PAGE.
Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method.
Storage Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.
Shipping This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C.
Formulation Supplied as a 0.2 μm filtered solution of 50mM HEPES, 150mM NaCl, 20% Glycerol, pH 7.4.
Reconstitution Not Applicable



Background

Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a secretory subtilase belonging to the proteinase K subfamily. PCSK9 is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the ER ; the pro domain and mature chain secrete together through noncovalent interactions. PCSK9 binds with low-density lipoprotein receptor (LDLR) and plays a major regulatory role in cholesterol homeostasis. Inhibition of PCSK9 function by preventing PCSK9/LDLR interaction is currently being explored as a means of lowering cholesterol levels. PCSK9 also binds to apolipoprotein receptor 2 (ApoER2); and play a role in the neural development.